212 related articles for article (PubMed ID: 24147430)
1. Nestin is a wide-spectrum abluminal cell marker of salivary gland tumors.
Yanai H; Sato Y; Nagatsuka H; Yoshino T
Pathol Int; 2013 Oct; 63(10):496-501. PubMed ID: 24147430
[TBL] [Abstract][Full Text] [Related]
2. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
4. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
5. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
6. Malignant salivary gland tumors and cyclo-oxygenase-2: a histopathological and immunohistochemical analysis with implications on histogenesis.
Akrish S; Peled M; Ben-Izhak O; Nagler RM
Oral Oncol; 2009 Dec; 45(12):1044-50. PubMed ID: 19729335
[TBL] [Abstract][Full Text] [Related]
7. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
[TBL] [Abstract][Full Text] [Related]
8. Expression and cellular localization of TSC-22 in normal salivary glands and salivary gland tumors: implications for tumor cell differentiation.
Doi Y; Kawamata H; Ono Y; Fujimori T; Imai Y
Oncol Rep; 2008 Mar; 19(3):609-16. PubMed ID: 18288391
[TBL] [Abstract][Full Text] [Related]
9. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
Ohtomo R; Mori T; Shibata S; Tsuta K; Maeshima AM; Akazawa C; Watabe Y; Honda K; Yamada T; Yoshimoto S; Asai M; Okano H; Kanai Y; Tsuda H
Mod Pathol; 2013 Aug; 26(8):1041-50. PubMed ID: 23558573
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin and E-cadherin expression in salivary gland tumors.
Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
12. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
[TBL] [Abstract][Full Text] [Related]
13. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Clauditz TS; Reiff M; Gravert L; Gnoss A; Tsourlakis MC; Münscher A; Sauter G; Bokemeyer C; Knecht R; Wilczak W
Pathology; 2011 Aug; 43(5):459-64. PubMed ID: 21670724
[TBL] [Abstract][Full Text] [Related]
15. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours.
Andreadis D; Epivatianos A; Poulopoulos A; Nomikos A; Papazoglou G; Antoniades D; Barbatis C
Oral Oncol; 2006 Jan; 42(1):57-65. PubMed ID: 16140564
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland.
Heikinheimo KA; Laine MA; Ritvos OV; Voutilainen RJ; Hogan BL; Leivo IV
Cancer Res; 1999 Nov; 59(22):5815-21. PubMed ID: 10582704
[TBL] [Abstract][Full Text] [Related]
17. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues.
Bilal H; Handra-Luca A; Bertrand JC; Fouret PJ
J Histochem Cytochem; 2003 Feb; 51(2):133-9. PubMed ID: 12533521
[TBL] [Abstract][Full Text] [Related]
18. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
19. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin expression in salivary gland pleomorphic adenoma.
Luo M; Takagi H; Tsubone M; Ando C; Ogata K; Shrestha P; Mori M
Arch Anat Cytol Pathol; 1993; 41(2):68-74. PubMed ID: 8239749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
